Publications by authors named "Nancy Dezutter"

Claim this Profile
E
Efficacy, safety, and immunogenicity of the AS01-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial.
Michael G Ison, Alberto Papi, Eugene Athan, Robert G Feldman, Joanne M Langley, Nancy Dezutter

Lancet Respir Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion F Protein Vaccine when Co-administered with Adjuvanted Seasonal Quadrivalent Influenza Vaccine in Older Adults: A Phase 3 Randomized Trial.
Rebecca Clark, Sam Davies, Jorge Labrador, Paul Loubet, Silvina Natalini Martínez, Nancy Dezutter

Clin Infect Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons.
Michael G Ison, Alberto Papi, Eugene Athan, Robert G Feldman, Joanne M Langley, Nancy Dezutter

Clin Infect Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of an AS01-adjuvanted respiratory syncytial virus prefusion F (RSVPreF3) vaccine in animal models.
Badiaa Bouzya, Ronan Nicolas Rouxel, Lionel Sacconnay, Romuald Mascolo, Laurence Nols, Nancy Dezutter

NPJ Vaccines· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains.
Lionel Sacconnay, Jonathan De Smedt, Vera Rocha-Perugini, Edison Ong, Romuald Mascolo, Nancy Dezutter

Sci Transl Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial.
Isabel Leroux-Roels, Matthew G Davis, Katie Steenackers, Brandon Essink, Corinne Vandermeulen, Nancy Dezutter

J Infect Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults.
Alberto Papi, Michael G Ison, Joanne M Langley, Dong-Gun Lee, Isabel Leroux-Roels, Nancy Dezutter

N Engl J Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput screening of excipients intended to prevent antigen aggregation at air-liquid interface.
Sébastien Dasnoy, Nancy Dezutter, Dominique Lemoine, Vivien Le Bras, Véronique Préat

Pharm Res· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.
Manuel J Cases-Thomas, John J Masters, Magnus W Walter, Gordon Campbell, Louise Haughton, Nancy A Dezutter

Bioorg Med Chem Lett· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.
Christopher D Beadle, John Boot, Nicholas P Camp, Nancy Dezutter, Jeremy Findlay

Bioorg Med Chem Lett· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis